GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of someone explain special authorization to me like I have not read a paper in years — 55 comments in the full submission. View in context.
1.6k
c/glp1canada·submitted 1 year ago by u/ffmi_watcher

someone explain special authorization to me like I have not read a paper in years

Questionbranch of 8 comments

someone explain special authorization to me like I have not read a paper in years, and I want the answer with the reasoning attached rather than just the conclusion. The three separate questions people ask here as though they were one. Is it approved for sale — a national regulatory question with one answer. Is it…

Read the full submission and all 55 comments →

This branch

8 comments, started 1 year ago
u/pavel_kravchenko143 points·1 year ago

Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing.

replysharereportpermalink
u/ravi_bergstrom0 points·1 year ago·edited

Confused a rejected claim with a denied authorization for a month and pursued entirely the wrong process.

replysharereportpermalink
u/omar_eriksen1 point·1 year ago

private plans and provincial plans are different fights entirely

replysharereportpermalink
u/ffmi_watcherOP1 point·1 year ago·edited

Compared cash prices across four pharmacies before pursuing coverage and the spread was larger than I expected.

replysharereportpermalink
[deleted]58 points·1 year ago

[deleted]

replysharereportpermalink
u/ffmi_watcherOP24 points·1 year ago

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

replysharereportpermalink
u/ffmi_watcherOP81 points·1 year ago

Have you asked the pharmacist to check?

replysharereportpermalink
u/pavel_kravchenko56 points·1 year ago

Small fix — that formulary position is another province’s and does not apply here.

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.